In November 2018, in partnership with charity Hope for Tomorrow, we launched our new mobile cancer care unit (MCCU). The state of the art MCCU, which is 6 car parking widths wide and has 4 treatment chairs, has been designed to enable flexibility for treatment locations, depending on where the patient need is greatest.

The new MCCU, brings cancer care closer to patients in their own community and is owned and maintained by Hope for Tomorrow and is provided along with a Nurses’ Support Vehicle which allows the nursing team to travel to and from the daily locations of the MCCU.

The locations the MCCU visits are:

Update

In November 2021 Airedale NHS Foundation Trust launched their latest mobile cancer unit – adding to its fleet, taking cancer care and treatments to the patient in Airedale, Wharfedale and Craven 5 days a week.

The Next Generation unit, provided by the charity Hope for Tomorrow, is a state-of-the-art fully mobile medical cancer care unit which revolutionises the way cancer care is delivered.  A new feature is the hydraulic sides – which move out to provide two clinic rooms, so providing a larger unit.

It will visit communities to provide accessible clinics as well as cancer treatments including chemotherapy.  Staffed by specialist oncology nursing teams and pharmacists the unit will allow cancer services to be delivered in the heart of the local community in venues including Skipton, Keighley, Bingley, Ilkley and Barnoldswick.

Moving cancer care closer to patients has proven health and wellbeing benefits as the reduced travel and waiting times can lower stress and anxiety levels for patients.  Staff also appreciate the different working environment, away from the hospital setting.  The unit will be used for clinics that are already in place but will now have them in the community, so patients can incorporate their appointments into their lives rather than fit their life around hospital appointments.

The trust received its first unit from Hope for Tomorrow in 2018 and had the use of an additional unit during the pandemic so vulnerable patients didn’t always need to come into hospital and they have both been a great success.

Pat Dyminksi, lead clinical nurse specialist for haematology, oncology and chemotherapy at Airedale NHS Foundation Trust says:

“We received our very first mobile unit three years ago today and it has had a huge impact on patients.  For me, the most important thing when setting these up was that patients would feel as safe in the mobile units as they do in hospital.

It was a vision to begin with, but it has been extremely successful and now three years on we are here using the units to their maximum potential.  If you’ve got the clinic space, the needs of patients and staff availability then the sky is the limit with what we can expand this to.”

Sheenagh Stapleton who lives near Settle was having to make a 40 mile round trip to receive treatment, but the Mobile Cancer Unit brought treatment closer to home.  She cut the ribbon at the launch event.

Sheenagh says “I’ve had 5 lots of chemotherapy sessions now and initially when I started they didn’t have the unit so my journey of 20 miles was on top of the chemo.  Now I can drive to Settle which is 5 minutes away, sit there and have 4-5 hours of treatment and go home.  It makes such a difference, it means I don’t have to get my family to come out of work to collect me and disrupt their day and I can get on with a normal routine rather than have everything turned upside down.

This unit is named ‘Christine’, in honour of the Hope for Tomorrow charity’s founder who died of cancer in 2018.

Hope for Tomorrow designed and launched their first mobile cancer care unit in 2007 in Cheltenham, Gloucestershire. Since then they have continually developed their fleet which grew to 13 units by the beginning of 2021. Eleven mobile cancer care units are currently allocated to NHS Trusts with two units remaining in reserve to ensure no interruptions to service. Throughout the Covid-19 crisis available reserve units were deployed to support NHS trusts wherever possible, allowing vital cancer services to continue.